Respiratory

Filter

Nebulized therapy concept for COPD symptom relief with ensifentrine

CHEST 2025: Ensifentrine Boosts Quality of Life in COPD

October 2025

Ensifentrine improved symptoms, dyspnea, and quality of life in stable COPD without exacerbations in ENHANCE trials.

Nebulized therapy concept for COPD symptom relief with ensifentrine

CHEST 2025: Ensifentrine Boosts Quality of Life in COPD

Ensifentrine improved symptoms, dyspnea, and quality of life in stable COPD without exacerbations in ENHANCE trials.

WCLC 2025: IFITM3 May Improve Immunotherapy Outcomes in SCLC

Interferon-induced transmembrane protein 3 (IFITM3) has been identified as a critical regulator of immunotherapy response in small cell lung cancer (SCLC), with new findings showing its potential role as both a predictive biomarker and therapeutic target.

Loading posts...